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Improved Endothelial Cell Attachment on ePTFE Vascular Grafts 
Pretreated with Synthetic RGD-containing Peptides 
K. P. Wa l luscheck  1., G. Ste inhof f  1, S. Ke lm 2 and A. Haver ich 1 
Department of 1Cardiovascular Surgery and 2 Institute of Biochemistry, University of Kiel, Germany 
Objectives: To assess endothelial ceil (EC) attachment i  seeding of expanded polytetrafluoroethylene ( PTFE) vascular 
prostheses by application of a new technique ofcoupling synthetic RGD-containing peptides with the graft surface. 
Design: Prospective, open study. 
Setting- University Department ofCardiovascular Surgery and Institute of Biochemistry. 
Materials and methods: ePTFE vascular grafts (group 1) uncoated (group 2) coated with fibronectin (group 3) coated 
with a RGD-containing peptide or (group 4) coated in a similar way to group 3 but without application of a RGD-peptide, 
were incubated for 30 min with adult human saphenous vein endothelial cells. After seeding, rafts were exposed to shear 
stress in an artificial flow circuit. EC attachment after seeding and retention after perfusion was assessed by scanning 
electron microscopy and image analysis. 
Main results: Both EC attachment and retention were significantly increased by coating with fibronectin i  comparison 
to uncoated ePTFE. Graft coating with an RGD-peptide l ad to the highest increase in EC attachment (30.6% + 2.1%) 
and retention after shear stress (62.9% + 7.5%) compared to fibronectin coated (26.0% + 3.3%/45.5% + 2.1%), 
uncoated (14.9% + 3.1%/13.9% +_ 7.9%) and similar coated ePTFE grafts without application of a RGD-peptide (10.5% 
+ 1.1%/6.6% +_ 1.5%). 
Conclusions: EC attachment onuncoated ePTFE vascular prostheses is very weak. Our technique ofcoupling the ePTFE 
graft surface with cell adhesion promoting RGD-containing synthetic peptides significantly improved this decisive step in 
endothelial cell seeding of ePTFE grafts. 
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Introduction 
Endothelial cell seeding of synthetic vascular prosthe- 
ses in vitro and in animal models is known to reduce 
platelet adhesion 1'2 and improve patency by the rapid 
establishment of a functional endothelial mono- 
67 layer. 3-5 After initial disappointment, ' similar esults 
could be obtained in human clinical trials also. 8-12 For 
successful clinical use, however, extensive pretreat- 
ment of the prosthetic surface is necessary. PTFE 
vascular grafts have been shown to provide very poor 
adherence to endothelial cells. Therefore, different 
techniques of pretreatment have been developed, 
using various matrix proteins for precoating the PTFE 
surface. The growing molecular understanding of
cellular adhesion mechanisms opened anew path into 
further efforts to increase EC attachment. Recent 
investigations have identified the RGD-tripeptide 
*Please address all correspondence to: Knut Peer Walluscheck, 
Klinik fiir Herz- u. Gef/it~chirurgie, Christian-Albrechts-Universitat 
Kiel, Arnold-Heller Str. 7, 24105 Kiel, Germany. 
sequence (arginine-glycine-aspartate) as the minimal 
amino acid attachment sequence of integrin cell matrix 
adhesion receptors to matrix proteins such as fibro- 
13 l _  nectin, laminin or tenascin. -
To improve EC attachment and retention by an 
increase in density of RGD-sites without application of 
plasma proteins we established a technique of precoat- 
ing ePTFE vascular prostheses using synthetic RGD- 
containing peptides. In our study, we compared 
precoating with an RGD-containing peptide to fibro- 
nectin coated, polylysine/glutardialdehyde coated 
and uncoated ePTFE prostheses. 
Materials and Methods 
Endothelial cell isolation, culture and characterisation 
Residual, usually discarded, segments of human 
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saphenous veins were obtained from patients under- 
going elective coronary artery bypass surgery. Speci- 
mens were transported to the laboratory in hep- 
arinised cold autologous blood. Adult human 
saphenous vein endothelial cells (AHSVEC) were 
harvested under sterile conditions using a modifica- 
tion of the methods described in previous tudies. 2°'21 
Vein segments were rinsed with Hanks balanced salt 
solution (Clintec Salvia GmbH, Homburg, Germany), 
then they were filled with a solution of 0.2% col- 
lagenase A (Boehringer, Mannheim, Germany) in PBS 
with Ca ~ ÷ and Mg 2 + (Sigma Chemical Co., St. Louis, 
MO, U.S.A.). The other end was closed by a small 
clamp with the vein being gently distended. With both 
ends occluded, the vessel was incubated for 20 min in 
Hanks solution in a 5% CO2 / 95% air atmosphere, at
37°C. The vein was flushed with 50 ml M-199 tissue 
culture medium with L-glutamine (Sigma Chemical 
Co.) containing 10% fetal bovine serum (FBS)(Sigma 
Chemical Co.), and the endothelial cells were pelleted 
by centrifugation for 5 min at 300 g. The cell pellet was 
resuspended in 5 ml culture medium consisting of 
M-199, 10% pooled human serum, 100 units/ml 
penicilline (Sigma Chemical Co.), 100/zg/ml strepto- 
mycin (Sigma Chemical Co.), 50 ~g/ml endothelial 
cell growth factor (Boehringer), 500 units/ml preserv- 
ative-free heparin (Heparin Novo, Nordisk, Mainz, 
Germany) and placed onto one well of a 6-well culture 
plate (Greiner, Frickenhausen, Germany) precoated 
with heat-inactivated pooled human serum obtained 
from healthy donors of blood type AB. 
The EC were grown to confluence at 37°C in an 
incubator (Forma Scientific, Marietta, GA, U.S.A.) 
under 5% CO2 and 95% air. The medium was replaced 
every 3 days. After reaching confluence, the EC were 
detached with 0.05% trypsin and 0.02% EDTA (Sigma 
Chemical Co.) in PBS without Ca2+/Mg 2+ and 
washed twice with M-199 containing 10% FBS, added 
to inactivate any residual trypsin. Cells were cen- 
trifugated as described, resuspended in culture 
medium and subcultivated in 75 cm2/culture flasks at 
the first passage and in 175 cm2/culture flasks up to 
the second passage. Endothelial cells from the second 
to third passage were utilised for EC seeding. To 
confirm the identity of cultured cells as being endothe- 
lial cells, samples were examined by immunohis- 
tochemistry for the presence of factor VIII-related 
antigen with the peroxidase-antiperoxidase reaction, 
and their typical morphological features were identi- 
fied by microscopy. 
Graft precoating 
Segments of expanded polytetrafluoroethylene 
(ePTFE) vascular grafts (Impra Medica GmbH, 
Munich, Germany), with an inside diameter of 0.4 cm 
and 6 cm in length, a wall thickness of 0.04 cm and a 
fibril length of approximately 60/~m, were used for 
each experiment. For instillation of precoating solu- 
tions and endothelial cells, as well as for integrating 
the graft into the artificial flow circuit, a modified Luer 
connector (Fresenius, Bad Homburg, Germany) was 
inserted into the graft at each end and fixed from 
outside by means of a ligature. Precoating solutions 
were applied by a standard syringe fitting to the 
connector. 
Study groups 
Group 1: uncoated ePTFE grafts. A control group of 
ePTFE grafts (n = 5) was used for seeding and 
perfusion. Prior to seeding rafts were filled with PBS 
and the solution forced through the interstices to 
remove air. There was no further pretreatment of the 
ePTFE grafts. 
Group 2: human fibronectin (HFN) coated ePTFE grafts. 
ePTFE grafts (n = 5) were filled with 40/xg/ml human 
plasma fibronectin (Gibco, Life Technologies Inc., 
Gaithersburg, MD, U.S.A.) in calcium/magnesium- 
free PBS and the solution was forced through the 
interstices of the ePTFE material. The HFN solution 
remained inside the gently distended graft for 24 h at 
room temperature and was then evacuated. 
Group 3: RGD-peptide coated ePTFE grafts, ePTFE grafts 
(n = 5) were filled with 40 /~g/ml poly-L-lysine 
hydrobromide (PL)(Sigma GmbH, Deisenhofen) in 
PBS, the solution was forced through the interstices 
and the grafts were incubated at room temperature for 
24 h to allow adsorption of the polypeptide to the 
ePTFE material (Fig. 1). After rinsing the graft with 
PBS, a solution of 0.2% glutardialdehyde (GA)(Sigma 
GmbH, Deisenhofen, Germany) in PBS was instilled 
into the grafts and left for 10 min. The glutardialde- 
hyde is binding by aldehyde groups to the primary 
amino groups of the precoated poly-L-lysine. The 
grafts were again rinsed with PBS. Now the grafts 
were completely filled with 1000/zg/ml of the RGD- 
sequence containing peptide (Gly-Arg-Gly-Ser-Pro- 
Lys)(Gibco) in PBS for 60 min. During this incubation, 
available aldehyde groups on the derivatized poly- 
lysine could bind primary amino groups of the RGD- 
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Fig. 1. Schematic drawing of biochemical reactions in promotion of EC attachment by polylysine-RGD-derivatives. Poly-L-lysine highly 
attachs to the artificial ePTFE material. (a) Glutardialdehyde is binding by aldehyde groups to the primary amino groups of polylysine. (b) 
The available aldehyde groups on the derivatized polylysine can bind primary amino groups of the synthetic RGD-peptides. (c) EC interact 
by integrin family of cell-matrix receptors with the wall bound RGD-sequence and adhere to the ePTFE graft. 
peptides, leading to polylysine-RGD-derivatives. 
After removing the peptide solution, a solution 
containing 1.0% bovine serum albumine (Sigma 
Chemical Co.) in PBS was instilled into the grafts for 
30 min to occupy any unbound aldehyde sites. Graft 
pretreatment was finished by a slight wash of the 
prostheses in PBS. 
Group 4: Polylysine / glutardialdehyde coated ePTFE grafts. 
ePTFE grafts (n = 5) were treated in a similar way to 
the protheses of study group 3 but without application 
of the RGD-peptide. 
of a syringe, occluded at both ends and incubated for 
30 min in a humidified incubator in a 5% CO2 / 95% 
air atmosphere at a constant emperature of 37°C. 
After 15 min the graft segments were rotated once by 
180 degrees. At the end of the seeding procedure 
grafts were rinsed briefly in culture medium and one 
of the Luer connectors was removed. A segment of 1 
cm length was dissected for scanning electron micros- 
copy (SEM). Then the Luer connector was replaced 
and the grafts were immediately placed into the 
artificial flow circuit. 
Endothelial cell seeding 
Uncoated ePTFE grafts (group 1), HFN coated (group 
2), RGD-peptide coated (group 3) and PL/GA coated 
grafts (group 4), were seeded with cultured AHSVEC. 
EC of the second to third passage were trypsinised, 
centrifugated and resuspended in complete culture 
medium as previously described. An aliquot was 
taken for cell counting in a hemocytometer (Fuchs- 
Rosenthal, Superior, Germany) and the cell suspen- 
sion adjusted to a confluent seeding density of 1.2 × 
105 EC/cm 2 to cover the available surface area of 6.3 
cm 2. Grafts were filled with the EC suspension by use 
In vitro per/usion in an artificial flow circuit 
To evaluate shear stress resistance and cell retention of 
seeded endothelial cells on ePTFE surfaces, an artifi- 
cial flow circuit was designed (Fig. 2). Pulsatile flow 
was produced in a closed, sterile system by using a 
roller pump (Medax, Kiel, Germany), a cardiotomy 
reservoir including a filter for perfusion medium and 
an air bubble filter (Sorin Biomedica, Saluggia, Italy) 
and standard extracorporal perfusion tubing (Jostra, 
Hirrlingen, Germany). Seeded ePTFE grafts, enclosed 
in a specially developed glass tube (Hampe, Kiel, 
Germany), were integrated into the flow circuit by 
previously inserted Luer connectors. The system was 
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primed with 500 ml of culture medium M-199 contain- 
ing 10% human serum and antibiotics as described. 
There was no addition of endothelial cell growth 
factor to the perfusion medium and temperature was 
maintained at 37°C by passage through a water bath. 
Before priming the system, the perfusion medium was 
incubated at 37°C and at a 5% CO2/95% room air 
atmosphere. In order to simulate flow rates in femor- 
opopliteal vein grafts 22'23 pressure was adjusted and 
kept constant at 35 mm of Mercur)~ measured by a 
membrane transducer and pressure monitor (Hewlett 
Packard, Andover, MD, U.S.A.). The circuit was 
calibrated for a flow rate of 100 ml / rain, which was 
maintained for i h. A resulting shear stress value of 2.9 
dynes/cm 2 was calculated as described by Vohra et 
al. 24 After perfusion both Luer connectors were 
removed from the graft, a defined central graft 
segment excised and prepared for SEM. 
Scanning electron microscopy (SEM) 
Specimens, 1 cm in length, of seeded and perfused 
10 
1 
11 
14 1 13 
2 3 
4 12 
Fig. 2. Schematic drawing of the artificial f ow circuit. Cardiotomy 
reservoir (1) with air bubble filter (2), perfusion medium filter (3), 
water bath (4), extracorporal perfusion tubing (5), membrane 
transducer (6), pressure and temperature monitor (7), glass tube 
enclosing the graft with in- and outlet for surrounding medium (8), 
seeded PTFE graft (9), temperature transducer (10), roller pump 
(11), priming culture medium (12), inlet for COe adjustment (13), 
inlet for culture medium (14). Arrows how direction of flow. 
grafts were evaluated by SEM for quantification and 
morphology of endothelial cells. Immediately after 
dissection from the prosthesis, samples were carefully 
prepared for SEM in a modification of previously 
described techniquesY '36 Graft segments were fixed 
in 2.5% glutardialdehyde for 4 h and rinsed in 
phosphate buffer. A post-fixation for 2 h in 2% 
osmium tetroxide in buffer followed. After dehydra- 
tion in graded series of ethanol solutions the samples 
were critical point dried with liquid CO2, sputter 
coated with gold / palladium in a vacuum evaporator 
(Ion Tech Ltd., Teddington, U.K.) and examined with a 
scanning electron microscope (Philips XL 20, Kassel, 
Germany), which was operated at an accelerating 
voltage of 25 kV. 
Photographs were taken at magnification × 618 
and recorded on Kodak Ektrachrome film (Kodak 
Ltd., U.K.). Further they were digitalised, stored on 
floppy disk and printed by use of a personal computer 
and laser printer (Hewlett Packard, London, U.K.). 
Prints were employed for measurement of percent EC- 
covered graft area, applying an image analysing 
device (IBAS-1, Kontron, Eichach, Germany). For this 
purpose, a segment of the graft circumference perpen- 
dicular to the main deposition force during the first 15 
rain of EC incubation had previously been marked. 
Therefore, investigated samples had been exposed to 
identical seeding density. Five randomly chosen sec- 
tions of each sample along an imaginary line of the 
selected segment were measured and the average 
calculated. Mean values from the five grafts of each 
group were calculated to determine EC adhesion. Data 
were expressed in percent of EC-covered area after 
seeding and after perfusion (mean + S.D.). EC reten- 
tion in percent was calculated by dividing the covered 
area of the perfused grafts in each group by the 
covered area of the seeded non-perfused grafts. The 
result was multiplied by 100. Data were analyzed for 
statistical significance using Wilcoxon test with p 
values less than 0.05 considered significant. 
Results 
A comparison of endothelial cell adhesion and reten- 
tion on uncoted and coated ePTFE vascular prosthe- 
ses, after seeding and after perfusion in an artificial 
flow circuit, was carried out. A summary of scanning 
electron microscopic results is depicted in Figs. 3-6. 
Group 1. In uncoated ePTFE vascular prostheses 14.9% 
+ 3.1% of the area assessed was covered with 
endothelial cells after 30 min of seeding 1.2 x 105 
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AHSVEC/cm 2. After perfusion, EC coverage was 
2.0% _+ 1.0%. Cell retention was 13.9% _+ 7.9% (see 
Figs. 7 and 8). 
Group 2. Precoating ePTFE grafts with human fibro- 
nectin resulted in an EC-covered surface after seeding 
of 26.0% + 3.3%. Applying shear stress in the artificial 
flow circuit resulted in a decrease to 11.8% + 1.6%. 
The calculated cell retention was 45.5% + 2.1% (see 
Figs. 7 and 8). EC adhesion after seeding and after 
perfusion, as well as EC retention were significantly 
(a) 
(p = 0.008 / 0.008 / 0.008) increased compared with 
group 1. 
Group 3. After pretreatment of ePTFE grafts with 
synthetic RGD-containing peptides an EC-covered 
area of 30.6% + 2.1% was observed. Perfusion of the 
PTFE grafts lead to an EC coverage of 19.3% + 2.8%. 
Endothelial cell retention was 62.9% + 7.5% (see Figs. 
7 and 8). EC adhesion after seeding, after perfusion 
and EC retention were significantly increased in group 
(a) 
(b) 
(b) 
Fig. 3. Scanning electron micrograph of an uncoated ePTFE graft 
(group 1). (a) after 30 rain of EC seeding (1.2 x 105 EC/cm z) and (b) 
after 1 h of perfusion in the flow circuit (100 ml/min). Original 
magnification × 618. The scale bar represents 20 ~m. Only a few 
rounded EC can be seen on the fibrils of the ePTFE material after 
seeding while after perfusion the remaining cells seem to be trapped 
by the ePTFE fibrils. 
Fig. 4. Scanning electron micrograph of a fibronectin coated ePTFE 
graft (group 2). (a) after 30 min of EC seeding (1.2 x 105 EC/cm 2) 
and (b) after 1 h of perfusion in the flow circuit (100 ml/min). 
Original magnification × 618. The scale bar represents 20/~m. A 
significant increase in EC coverage of the graft surface can be seen 
after precoating the artificial material with fibronectin. EC start 
spreading after 30 min of seeding but there is a high cell loss after 
application of shear stress. 
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3 compared  to group  1 (p = 0.008 / 0.008 / 0.008). In 
compar i son  to group  2 there was  an increase in EC 
adhes ion  after seeding,  after per fus ion  and in reten- 
tion, but  there was  statist ical s ignif icance on ly  after 
per fus ion and  in EC retent ion (p = 0.056 / 0.008 / 
0.0O8). 
Group 4. Precoat ing ePTFE protheses imi lar  to group  
3 but  w i thout  app l icat ion  of a RGD-pept ide  resu l ted 
in an EC-covered area after seed ing of 10.5% + 1.1%. 
After perfus ion,  EC coverage was  0.7% + 0.2%. EC 
retent ion was  6.6% + 1.5% (see Figs. 7 and  8). There 
was  a signif icant decrease in EC adhes ion  in group 4 
in all parameters  invest igated between the s tudy  
groups  except for EC retent ion between group  4 and  
group  1 (group 4 / g roup  1: p = 0.032 / 0.008 / 0.095 - 
g roup  4 / g roup  2: p = 0.008 / 0.008 / 0.008 - g roup  
4 / group 3: p = 0.008 / 0.008 / 0.008). 
(a) (a) 
(b) (b) 
Fig. 5. Scanning electron micrograph of an ePTFE graft coated with 
a RGD-peptide (group 3). (a) after 30 min of EC seeding (1.2 × 10 s 
EC/cm ~) and (b) after 1 h of perfusion in the flow circuit (100 ml/ 
min). Original magnification × 618. The scale bar represents 20/zm. 
Immediately after seeding the graft surface is covered with a high 
number of rounded and spreading EC. After perfusion the 
significantly highest increase in EC coverage compared with the 
other study groups can be deomonstrated. EC show an unaffected 
morphology and very good spreading. 
Fig. 6. Scanning electron micrograph of an ePTFE graft coated with 
polylysine, glutardialdehyde and albumin (group 4) similar to 
precoating ofgroup 3 but without app_lication ofa RGD-peptide. (a) 
5 2 after 30 rain of EC seeding (1.2 × 10 EC/cm ) and (b) after 1 h of 
perfusion in the flow circuit (100 ml/min). Original magnification 
× 618. The scale bar represents 20 ~m. This precoating technique 
has the lowest EC adhesion after seeding and after perfusion. 
Therefore, the RGD-sequence has a decisive influence on EC 
adhesion. 
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Fig. 7. Comparison f EC adhesion on uncoated, fibronectin (HFN) 
coated, RGD-peptide (RGD) coated and polylysine/glutardialde- 
hyde (PL/GA) coated ePTFE grafts. EC-covered area (%) after 30 
min of seeding (1.2 × 105 EC/cm 2) and after 60 min of perfusion i
a flow circuit (100 ml/min). Calculated standard eviation i  
brackets. (ll) after seeding; ([~) after perfusion. 
Discussion 
Autologous blood vessel substitutes have been shown 
to exhibit significant advantages over prosthetic graft 
materials both in peripheral vascular and coronary 
bypass surgery. Albeit not genetically structured for 
use in the arterial circulation, the saphenous vein still 
demonstrates superio~ short and long-term function 
compared to artificial small calibre prostheses. Its 
biologic inner surface, activating numerous mechan- 
ical and metabolic properties, is thought to be of 
decisive importance to blood flow and coagulation. 
Availability, however, is limited. Therefore, two major 
aims of research ave been followed during the past 
60 
50 
~ 40 
,~ 30 c~ 
20 
10 
62.9 
(7.5) 
Uncoated HFN RGD PL/GA 
Group i Group 2 Group 3 Group 4 
Fig. 8. Comparison of EC retention (calculated by dividing the 
averaged covered area of the perfused grafts in each group by the 
averaged covered area of the seeded non perfused grafts and 
multiplication by100) on uncoated, fibronectin (HFN) coated, RGD- 
peptide (RGD) coated and polylysine/glutardialdehyde (PL/GA) 
coated ePTFE grafts. Calculated standard deviation i brackets. 
decade beyond improvement of chemical and physical 
composition of prosthetic materials: the use of allo- 
and xenogeneic blood vessels and of autologous EC 
on artificial surfaces. 
Allotransplantation of cryopreserved saphenous 
veins has been limited by availability, and use of 
arterial substitutes from animals has been shown to be 
inferior to autologous graft material. Endothelial cell 
seeding of prosthetic graft material using autologous 
tissue, by contrast, has resulted in highly variable 
success rates, probably depending on the homoge- 
nicity of the inner surface applied to the prosthetic 
fabric and its durability. In this study, pretreatment of 
ePTFE vascular prostheses, using adhesion promoting 
RGD-peptides in a new technique of coupling the 
peptides with the graft surface, did significantly 
increase retention of seeded endothelial cells com- 
pared with uncoated grafts, PL/GA coated grafts and 
prostheses coated with fibronectin. This finding may 
have significant impact on the progress of autologous 
EC seeding in vascular surgical procedures using 
small caliber prosthetic replacement. 
For more than 10 years, numerous experimental nd 
clinical studies have been performed to investigate 
precoating techniques of artificial prosthetic surfaces. 
Synthetic graft materials such as Dacron, 3"~2"26-31 
Teflon, 32 polyurethane 33'34 and particularly polytetra- 
fluoroethylene (PTFE) 9'1°'35-B7 were used. It was recog- 
nised that laminin and collagen were able to enhance 
EC attachment. 38'39 Fibronectin, which is considered to 
be the major target substance of cell adhesion, 4°
reliably improves EC adherence on PTFE sur- 
faces. 20'36"38"39'41-43 Transglutinine, as a biologic adhe- 
sive substance, was shown to be as good as fibronectin 
in supporting EC adhesion on PTFE. 44 In vitro coating 
of PTFE prostheses by use of fibrin glue was superior 
to blood preclotting. 45This technique, including dif- 
ferent steps of fibrinogen-coating, thrombin-coating 
and the application of a balloon catheter, was repeat- 
edly used in human clinical studies of peripheral 
vascular econstruction. 6-1° 
Increased EC adhesion on artificial surfaces can 
definitely be obtained by any of the methods 
described. There are, however, certain disadvantages 
of some of these procedures, Complicated and long- 
lasting precoating prior to seeding impedes wide 
spread clinical application. A potential transfer of viral 
infections from precoating with human plasma com- 
ponents uch as fibrin glue should be avoided as well. 
In addition, thrombin and fibrin are highly thrombo- 
genic if applied intravascularly. Both substances may 
potentially precipitate coagulation, if a confluent EC 
monolayer cannot be obtained soon after seeding. 
Furthermore, fibrin glue has been alleged to initiate 
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immunologic reactions. 46 Finall~ any of these tech- 
niques should also be applicable to other surfaces than 
PTFE, such as pump chambers of ventricular assist 
devices and native vascular surfaces. 
In 1984, Pierschbacher t al. 47 determined the RGD- 
tetrapeptide to constitute the main cell attachment 
domain of fibronectin. This site is recognised by 
13 14 integrin receptors of endothelial cells ' and different 
other cells 13'18'47'48 to form cell-matrix adhesion. It was 
furthermore discovered in other extracellular matrix 
proteins like laminin 16'18 and tenascin. 14 Synthetic 
RGD-containing peptides were found to either dupli- 
cate or inhibit cell attachment because of differences in 
structure 13 and they may also be more selective for 
receptors than peptides modelled after the natural 
sequences of extracellular matrix proteins. ~5 Previous 
investigations were performed using RGD-peptides in 
mediating cellular adhesion on artificial materials. 49-53 
In our study we decided to compare the application of 
such an RGD-peptide on ePTFE, as a polylysine-RGD- 
derivative, with fibronectin precoating because of the 
predominant role of the latter in mediating cell 
attachment. As shown previously, the direct compar- 
ison of EC adhesion with seeding of uncoated PTFE 
grafts revealed a significant advantage of fibronectin 
coating. This finding was amplified by application of 
shear stress during in vitro perfusion. Accordingl~ 
application of a maximally effective precoating con- 
centration of fibronectin 54 resulted in significantly 
higher EC adhesion after seeding and retention 
following perfusion. 
Pretreatment of ePTFE grafts with a synthetic 
adhesion promoting RGD-containing peptide resulted 
in 30.6% + 2.1% EC-covered graft area after seeding, 
which was significantly increased in relation to uncoa- 
ted grafts (14.9% + 3.1%) and comparable with 
fibronectin coated grafts (26.0% _+ 3.3%). These 
findings are in contrast o the results of Sank et aI. 52 
who found that EC adhesion on RGD-peptide coated 
PTFE was slightly less than on fibronectin coated 
PTFE. This can be explained by several important 
differences in our experimental set up. Firstly, a 
different peptide at a lower concentration was used by 
Sank et aI. and secondly, seeding was performed with 
umbilical vein EC, whereas we used saphenous vein 
EC. Furthermore, Sank et aI. used PTFE patches as 
opposed to tubular ePTFE grafts utilised in our study. 
Unfortunatel~ Sank et aI. did not define the fibril 
length of the PTFE material used. The decisive 
difference, however, may be the application of the 
precoating technique in our experiments, which has 
not been described before. Instead of simply incubat- 
ing the RGD-peptide with the PTFE material, we used 
two intermediate steps to bind the peptide to the wall 
of the prosthetic surface. This is supposed to result in 
a higher yield of wall-bound peptide, thereby provid- 
ing a tighter peptide connection to the graft. Sub- 
sequent EC retention to shear forces therefore may be 
increased. To prove that the decisive ffect of our new 
precoating technique is determined by the application 
of a RGD-peptide we investigated the EC adhesion by 
providing an identical graft precoating but without 
application of the RGD-peptide. In this study group 
(group 4) EC adhesion and retention were sig- 
nificantly decreased compared with the RGD-precoat- 
ing (group 3). In comparison to the uncoated ePTFE 
prostheses there was a significant decrease in EC 
adhesion after seeding and after perfusion as well. In 
our opinion this could be due to incompletely satisfied 
aldehyde groups. By application of RGD-peptides 
these aldehyde groups could be bound by a high 
concentration of available amino groups, what maybe 
was not possible in identical extend by the application 
of albumine. 
Increased resistance to shear stress was assessed by 
the degree of EC adhesion and retention after perfu- 
sion of the seeded ePTFE grafts in an artificial flow 
circuit. Whereas on RGD-peptide coated grafts 19.3% 
+ 2.8% EC-covered area could be seen after perfusion, 
fibronectin coated grafts showed 11.8% + 1.6%, and 
on uncoated grafts only 2.0% + 1.0% of the graft 
surface was covered with EC. On PL/GA coated grafts 
the lowest EC adhesion after perfusion was found 
(0.7% + 0.2% EC-covered area). These data were 
supported by evaluation of EC retention. GA/PL 
coated grafts showed only 6.6% + 1.5% and uncoated 
grafts 13.9% + 7.9% of the originally attached EC 
adherent after exposure to lh of shear stress. On 
fibronectin coated grafts an EC retention of 45.5% + 
2.1% was measured. The significantly highest EC 
retention of 62.9% + 7.5% could be seen on adhesion 
promoting RGD-peptide coated ePTFE grafts. While 
52 Sank et aI. have not investigated the rate of EC loss 
after applying shear stress, Wigod et al. 53 placed 
seeded ePTFE patches in a swinging bucket rotor 
centrifuge. In their stud~ a RGD-peptide was applied 
to ePTFE material which previously underwent 
removal of gas nuclei and treatment with the surfac- 
tant tridolecylmethylammonium chloride. With this 
mode of pretreatment EC retention was significantly 
decreased compared with fibronectin coating. The 
forces applied to endothelial cells in their study are 
not analogous to biologic flow conditions and cannot 
be compared with shear stress applied by our perfu- 
sion device. Nevertheless, the data obtained support 
our results in that initial bonding of RGD-peptides to 
the ePTFE material will improve EC adherence and 
retention. 
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With regard to the thrombogenicity of a RGD- 
coated graft surface, we have to consider that the 
RGD-sequence is recognised not only by endothelial 
integrin receptors but also by platelet adhesion mole- 
cules. 5s'56 Nevertheless, we assume a RGD-treated 
graft to be less thrombogeneic than a fibrin or 
fibronectin coated graft, because the small RGD- 
molecule, if exposed to blood flow, may be split much 
faster by proteases. This hypothesis, however, has to 
be proved by in vivo experiments. The application of 
glutardialdehyde, which is known to be a cell toxic 
substance, during the RGD-precoating process in our 
opinion has no detrimental effect on EC. This is 
confirmed by an unaffected cell morphology and 
spreading 90 min after outset of EC seeding. Damage 
of the graft surface or decrease in graft compliance by 
influence of GA we do not suppose because the 
concentration f GA is very low and application time 
is short. Furthermore, the ePTFE material is not 
containing available amino groups to be altered by 
reactive groups of the GA. 
We conclude from our results that endothelial cell 
attachment on ePTFE can be improved by specific 
bonding between adhesion promoting RGD-peptides 
and the artificial material. Further studies are neces- 
sary to find out whether EC growth kinetics on RGD- 
peptide pretreated PTFE vascular prostheses in vitro 
and in vivo are suitable for the rapid formation of a 
confluent endothelial monolayer in the clinical setting 
of arterial vascular econstruction using such grafts. 
The potential of using additional peptides or adhesion 
molecules with properties to enhance cell spreading 
and growth should be examined. It is also necessary to
evaluate, whether synthetic RGD-peptides can be 
employed on other biological and prosthetic vascular 
surfaces, such as pump chambers of ventricular assist 
devices. 
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